Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ahlam Shary J Hazazi"'
Autor:
Ahmed Abdelsamie Fadl, Alruwaili Nawaf Raji D, Nebras Omar Jaber Bedair, Ibrahim Hassan Almousaedi, Hadeel Salem Alwagdani, Shahad Bassam Sindi, Alhanoof Abdulhakeem Hazazi, Ahlam Shary J Hazazi, Mukhtar Marah Wasel A, Howra Wasel Alhashim, Abdulhakeem Abdullah M, Fatimah Abdulkareem Bin Amer, Alomair Abdulrahman Mohammed
Publikováno v:
International Journal of Life Science and Pharma Research. :L37-L49
Neurogenic bowel dysfunction (NBD) is fecal incontinence or constipation which is prevalent in kids with both congenital and acquired neurological disorders. NBD results from loss of normal sensory or motor control and may include both the upper and
Autor:
Mohammad Hussen Sheikh, Abeer Mohammed M Alanazi, Dina Ahmed Aljohani, Lama Mueysh M Aljohani, Manal Mohammed S Alatawi, Ahlam Shary J Hazazi, Amal Abutaleb M Qaysi, Dhuha Abdullah H ALQasir, Sarah Awad M Alenzi, Ibtisam Shary J Hazazi, Alhanoof Abdulhakeem Hazazi, Shouq Abdullah O Alwabisi, Renad Mohammed H Alanazi, Alaa Ayoub Baqadu
Publikováno v:
Cureus.
Autor:
Rinad Rasheed M. Alrashidi, Ohoud Abdullah Almutari, Badaya Awadh M. Alshehri, Rawan Ahmed H. Alshehri, Amal Abutaleb M. Qaysi, Mona Awad O. Al Balawi, Rawan Hamdi Bedaiwi, Rahf Mohammed I. Alqarni, Yara Abdulrahman Alali, Ahlam Shary J. Hazazi, Ibtisam Shary J. Hazazi, Alanoud Abdullah Alharbi, Ashwaq Nafea O. Alanazi, Rawan Hamoud M. Alatawi, Mohammed Hussen Sheikh
Publikováno v:
Journal of Pharmaceutical Research International. :249-254
Favism is most common in those who have G6PD deficiency from the Mediterranean region. As hemolytic anaemia is the most common complication of G6PD deficiency, and it can be life-threatening in certain people. Infection, hyperglycemia, certain meals,
Autor:
Maisaa Mokhtar M. Yousuf, Atheer Mansour E. Alatawi, Yara Abdulrahman Alali, Nouf Ali Alatawi, Ibtisam Shary J. Hazazi, Nujud Abdulqader Albalawi, Dimah Mohammed A. Abu Murad, Ahlam Shary J. Hazazi, Rahf Mohammed I. Alqarni, Badaya Awadh M. Alshehri
Publikováno v:
Journal of Pharmaceutical Research International. :139-147
Juvenile idiopathic arthritis (JIA) is a broad term that refers to a clinically heterogeneous group of arthritis that develops before the age of 16 and has no recognized cause. JIA treatment has evolved during the last two decades. Clinical trials re